Skip to content

VanishPoint® 24311

by Retractable Technologies, Inc.

VanishPoint® 24311 is a Class II device made by Retractable Technologies, Inc., listed in FDA GUDID since 16 Nov 2016 (UDI-DI 00613703243102), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00613703243102 UDI-DI Date16 Nov 2016ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
VanishPoint®
Generic name
Blood collection set, invasive
Model / Ref / Catalog
24311
Primary DI / UDI-DI
00613703243102
FDA product code
JKA, FPA
GMDN term
Blood collection set, invasive
Device class
Class II
Regulation number
862.1675, 880.5440
GUDID distribution status
In Commercial Distribution

Related devices

Category: Blood collection set, invasive

Similar devices in this category

Other devices filed under Blood collection set, invasive.

Other devices from Retractable Technologies, Inc.

See all devices from Retractable Technologies, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (10, all answered No)